Impact of asthma on anxiety, depression, and quality of life: a Moroccan study

Abstract

Aim: This study aims to investigate the impact of asthma on quality of life, explore its associations with anxiety and depression, and identify the key determining factors. Methods: A cross-sectional study was conducted in the pulmonology department of Hassan II University Hospital in Fez in 2021. Data were collected using an anonymous questionnaire that included sociodemographic, clinical, and therapeutic information. The Moroccan versions of the Hospital Anxiety and Depression Scale (HADS) and the Short-Form-12 (SF-12) scale were used to assess anxiety, depression, and quality of life. Descriptive analysis was performed, followed by univariate analysis to examine the associations between quality of life, anxiety, depression, and other factors, using statistical tests appropriate for the types of variables studied. A p<0.05 was considered statistically significant. Data entry was performed using Excel 2013, and statistical analysis was conducted using SPSS version 26. Results: Among the 67 patients included (77.6% women, 61.2% aged ≥ 50 years), wheezing (44.8%) and dyspnoea (26.9%) were the most frequent symptoms. Depression was significantly associated with pain (p=0.020), and frequent hospitalizations (p=0.021), while anxiety was more common among women (p=0.034). For quality of life, patients with depression had lower physical component summary (PCS) scores (p=0.008). Patients over 50 years old had significantly lower PCS and mental component summary (MCS) scores (p=0.001 and p=0.002, respectively). Illiterate patients had lower PCS scores (p=0.022), hypertensive patients had lower PCS scores (p=0.032), and a nearly significant difference for the MCS (p=0.053). Diabetic patients had lower MCS scores (p=0.034). Finally, a positive correlation was observed between respiratory function forced expiratory volume in 1 second (FEV₁) and both PCS scores (p=0.025) and MCS scores (p=0.018). Conclusions: This study underscores the importance of an integrated approach to enhancing the quality of life of asthmatic patients, taking into account respiratory, psychological, and social factors.

Keywords

Asthma / quality of life / anxiety / depression

References

[1] Asthme [Internet]. OMS; c2025 [cited 24 Dec 2024]. Available from: https://www.who.int/fr/news-room/fact-sheets/detail/asthma

[2] Song P, Adeloye D, Salim H, Santos JPD, Campbell H, Sheikh A, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. J Glob Health. 2022; 12: 04052.

[3] Li Y, Wang P, Shao X, Peng F, Lv D, Du H, et al. Asthma prevalence based on the Baidu index and China's Health Statistical Yearbook from 2011 to 2020 in China. Front Public Health. 2023; 11: 1221852.

[4] Wang Y, Guo D, Chen X, Wang S, Hu J, Liu X. Trends in asthma among adults in the United States, National Health and Nutrition Examination Survey 2005 to 2018. Ann Allergy Asthma Immunol. 2022; 129: 71-8.e2.

[5] Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, et al. Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program. BMC Pulm Med. 2018; 18: 68.

[6] Muanprasong S, Taneepanichskul N. Improving asthma management and enhancing quality of life for adults in Thailand. IJIRSS. 2024; 7: 1491-8.

[7] Ahmed NH, Elsalam SNA, Mohamed IA. Health Related Quality of Life for Patients with Bronchial Asthma. Egypt J Health Care. 2024; 15: 141-54.

[8] Karsaneh OAA, Anber AA, Shboul SA, Alrjoub M, Almashaqbeh OI, Alqaisi M, et al. Impact of Anxiety and Depression on the Level of Asthma Control Among Jordanian Adults with Asthma. J Asthma Allergy. 2024; 17: 463-76.

[9] Chaisuksant S, Somruesaen T, Khamsai S, Sawanyawisuth K. Anxiety and depression in patients with asthma in Thailand. Gazzetta Medica Italiana. 2024; 183: 305-9.

[10] Cunha MS, Amaral R, Pereira AM, Almeida R, Alves-Correia M, Loureiro CC, et al. Symptoms of anxiety and depression in patients with persistent asthma: a cross-sectional analysis of the INSPIRERS studies. BMJ Open. 2023; 13: e068725.

[11] 2022 GINA Main Report [Internet]. Global Initiative for Asthma; c2025 [cited 24 Dec 2024]. Available from: https://ginasthma.org/gina-reports/

[12] Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34: 220-33.

[13] Obtel M, Rhazi K, Elhold S, Benjelloune M, Gnatiuc L, Nejjari C. Cross-cultural adaptation of the 12-Item Short-Form survey instrument in a Moroccan representative Survey. South Afr J Epidemiol Infect. 2013; 28: 166-71.

[14] Jr JEW, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473-83.

[15] Ware J, Kosinski M, Turner-Bowker D, Gandek B. How to score SF-12 items. SF-12 v2: How to Score Version 2 of the SF-12 Health Survey. JANV. 2002; 2938.

[16] Wang DY, Ghoshal AG, Bin Abdul Muttalif AR, Lin HC, Thanaviratananich S, Bagga S, et al. Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific-Asia-Pacific Burden of Respiratory Diseases Study. Value Health Reg Issues. 2016; 9: 72-7.

[17] Bendahhou K, Serhir Z, Ibrahim Khalil A, Radallah D, Amegrissi S, Battas O, et al. Validation de la version dialectale Marocaine de l’échelle «HADS». Rev Epidemiol Sante Publique. 2017; 65: S53.

[18] Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-70.

[19] Botega NJ, Bio MR, Zomignani MA, Jr CG, Pereira WA. Mood disorders among medical in-patients: a validation study of the hospital anxiety and depression scale (HAD). Rev Saude Publica. 1995; 29: 355-63.

[20] Rabelo LM, Jaques SC, Szlichta L de L, Bessa MA do SMR. Prevalência de transtorno de depressão e ansiedade em pacientes com asma grave / Prevalence of depression and anxiety disorders in patients with severe asthma. Arq Med Hosp Fac Cienc Med Santa Casa São Paulo. 2024; 69: e9.

[21] Laumet G, Edralin JD, Dantzer R, Heijnen CJ, Kavelaars A. CD3⁺ T cells are critical for the resolution of comorbid inflammatory pain and depression-like behavior . Neurobiol Pain. 2020; 7: 100043.

[22] Tribuntceva LV, Васильевна ТЛ, Budnevsky AV, Валериевич БА, Prozorova GG, Гаральдовна ПГ, et al. Quality of life of patients with asthma: the effects of overweight, obesity and multimorbidity. Russian Family Doctor. 2024; 28: 5160.